scott galloway glp 1 on GLP-1 Drugs (4 min) The Real Downside of GLP-1

GLP-1 medications carry real contraindications that this overview would be incomplete without addressing directly

Ready to Take a Smarter Approach to Metabolic Health

Keeping the Weight Off After Menopause Weight Loss Because appetite returns if a GLP-1 is reduced or stopped, the maintenance plan is as important as the weight loss itself, and it should be built from the start rather than scrambled together at the end

2023 Nov 16;9(1):7

A recent post hoc analysis of the SURPASS-1 through SURPASS-5 clinical trials further supports tirzepatide having a renal-protective action [96]

Tirzepatide: Dual GLP-1 and GIP Receptor Agonist Tirzepatide represents the next evolution in peptide therapy because it activates not just GLP-1 receptors but also GIP (glucose-dependent insulinotropic polypeptide) receptors